Kalipso Chalkidou

9.7k total citations · 4 hit papers
115 papers, 5.5k citations indexed

About

Kalipso Chalkidou is a scholar working on Economics and Econometrics, General Health Professions and Finance. According to data from OpenAlex, Kalipso Chalkidou has authored 115 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Economics and Econometrics, 60 papers in General Health Professions and 25 papers in Finance. Recurrent topics in Kalipso Chalkidou's work include Health Systems, Economic Evaluations, Quality of Life (81 papers), Healthcare cost, quality, practices (28 papers) and Healthcare Policy and Management (28 papers). Kalipso Chalkidou is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (81 papers), Healthcare cost, quality, practices (28 papers) and Healthcare Policy and Management (28 papers). Kalipso Chalkidou collaborates with scholars based in United Kingdom, United States and Thailand. Kalipso Chalkidou's co-authors include Sean Tunis, Merrick Zwarenstein, Eduardo Bergel, Shaun Treweek, Douglas G. Altman, Kevin E. Thorpe, Curt D. Furberg, David J. Magid, Ian Harvey and Andrew D Oxman and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Kalipso Chalkidou

111 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A pragmatic–explanatory continuum indicator summary (PRECIS): a tool to help trial designers

2009 986 citations Kevin E. Thorpe, Merrick Zwarenstein et al. Journal of Clinical Epidemiology profile →
NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4

2018 816 citations Kalipso Chalkidou et al. profile →
Evidence for overuse of medical services around the world

2017 604 citations Kalipso Chalkidou et al. profile →
NCD Countdown 2030: pathways to achieving Sustainable Development Goal target 3.4

2020 260 citations Kalipso Chalkidou et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kalipso Chalkidou United Kingdom	30	2.2k	2.0k	1.0k	575	507	115	5.5k
Asaf Bitton United States	36	1.2k 0.6×	2.2k 1.1×	723 0.7×	595 1.0×	496 1.0×	128	5.9k
Gert P. Westert Netherlands	47	2.3k 1.0×	3.5k 1.8×	1.4k 1.3×	402 0.7×	360 0.7×	255	8.1k
Laurence C. Baker United States	49	2.7k 1.3×	4.2k 2.1×	2.0k 2.0×	331 0.6×	685 1.4×	213	10.2k
Atle Fretheim Norway	47	2.0k 0.9×	3.5k 1.7×	2.0k 2.0×	367 0.6×	1.2k 2.4×	185	8.2k
Jan De Maeseneer Belgium	36	976 0.4×	2.5k 1.2×	1.1k 1.1×	264 0.5×	500 1.0×	194	5.7k
Jonathan P. Weiner United States	44	2.4k 1.1×	3.6k 1.8×	1.5k 1.4×	434 0.8×	373 0.7×	188	8.4k
Melanie Bertram Switzerland	31	747 0.3×	856 0.4×	765 0.8×	481 0.8×	462 0.9×	78	3.8k
Dana Gelb Safran United States	48	3.4k 1.5×	5.2k 2.6×	995 1.0×	580 1.0×	320 0.6×	91	8.2k
Tessa Tan-Torres Edejer Switzerland	25	1.1k 0.5×	1.1k 0.5×	785 0.8×	215 0.4×	633 1.2×	41	3.9k
John Hsu United States	39	1.8k 0.8×	2.0k 1.0×	495 0.5×	322 0.6×	248 0.5×	171	4.9k

Countries citing papers authored by Kalipso Chalkidou

Since Specialization

Citations

This map shows the geographic impact of Kalipso Chalkidou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kalipso Chalkidou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kalipso Chalkidou more than expected).

Fields of papers citing papers by Kalipso Chalkidou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kalipso Chalkidou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kalipso Chalkidou. The network helps show where Kalipso Chalkidou may publish in the future.

Co-authorship network of co-authors of Kalipso Chalkidou

This figure shows the co-authorship network connecting the top 25 collaborators of Kalipso Chalkidou. A scholar is included among the top collaborators of Kalipso Chalkidou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kalipso Chalkidou. Kalipso Chalkidou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Igiraneza, Grace, et al.. (2024). Rapid cost-effectiveness analysis: hemodialysis versus peritoneal dialysis for patients with acute kidney injury in Rwanda. Cost Effectiveness and Resource Allocation. 22(1). 35–35. 1 indexed citations

Whitty, Jennifer A., Peter Littlejohns, Julie Ratcliffe, et al.. (2023). Impact of information and deliberation on the consistency of preferences for prioritization in health care – evidence from discrete choice experiments undertaken alongside citizens’ juries. Journal of Medical Economics. 26(1). 1237–1249.

Angelis, Aris, Martin Harker, John Cairns, et al.. (2023). The Evolving Nature of Health Technology Assessment: A Critical Appraisal of NICE’s New Methods Manual. Value in Health. 26(10). 1503–1509. 8 indexed citations

Ruiz, Francis, Kalipso Chalkidou, Abha Mehndiratta, et al.. (2021). Adaptive health technology assessment to facilitate priority setting in low- and middle-income countries. BMJ Global Health. 6(4). e004549–e004549. 30 indexed citations

Teerawattananon, Yot, Chris Painter, Saudamini Vishwanath Dabak, et al.. (2021). Avoiding health technology assessment: a global survey of reasons for not using health technology assessment in decision making. Cost Effectiveness and Resource Allocation. 19(1). 62–62. 19 indexed citations

Jain, Vageesh, et al.. (2021). Evaluations of public health interventions produced by health technology assessment agencies: A mapping review and analysis by type and evidence content. Health Policy. 125(8). 1054–1064. 5 indexed citations

Gheorghe, Adrian, Kalipso Chalkidou, Omar Shamieh, et al.. (2020). Economics of Pediatric Cancer in Four Eastern Mediterranean Countries: A Comparative Assessment. JCO Global Oncology. 6(6). 1155–1170. 7 indexed citations

Hollingworth, Samantha, Martha Gyansa‐Lutterodt, Justice Nonvignon, et al.. (2019). Implementing health technology assessment in Ghana to support universal health coverage: building relationships that focus on people, policy, and process. International Journal of Technology Assessment in Health Care. 36(1). 8–11. 18 indexed citations

Cohen, Joshua T., Kalipso Chalkidou, Yot Teerawattananon, et al.. (2019). Adherence to the iDSI reference case among published cost-per-DALY averted studies. PLoS ONE. 14(5). e0205633–e0205633. 27 indexed citations

10.

Wilkinson, Thomas, Kalipso Chalkidou, Damian Walker, et al.. (2019). International Decision Support Initiative reference case for health economic evaluation. Faculty of 1000 Research Ltd. 8. 841. 1 indexed citations

11.

Teerawattananon, Yot, Raoh‐Fang Pwu, Jeonghoon Ahn, et al.. (2018). HISTORICAL DEVELOPMENT OF THE HTAsiaLINK NETWORK AND ITS KEY DETERMINANTS OF SUCCESS. International Journal of Technology Assessment in Health Care. 34(3). 260–266. 19 indexed citations

12.

Luz, Alia, et al.. (2017). How Should Global Fund Use Value-for-Money Information to Sustain its Investments in Graduating Countries?. International Journal of Health Policy and Management. 6(9). 529–533. 3 indexed citations

13.

Hernández-Villafuerte, K., et al.. (2015). International Decision Support Initiative (iDSI): Mapping of priority-setting in health in 17 low and middle countries across Asia, Latin America, and Africa. RePEc: Research Papers in Economics. 1 indexed citations

14.

Scuffham, Paul, Julie Ratcliffe, Elizabeth Kendall, et al.. (2014). Engaging the public in healthcare decision-making: quantifying preferences for healthcare through citizens’ juries. BMJ Open. 4(5). e005437–e005437. 32 indexed citations

15.

Chalkidou, Kalipso, Patricio V. Marquez, Preet K. Dhillon, et al.. (2014). Evidence-informed frameworks for cost-effective cancer care and prevention in low, middle, and high-income countries. The Lancet Oncology. 15(3). e119–e131. 106 indexed citations

16.

Lopert, Ruth, Francis Ruiz, & Kalipso Chalkidou. (2013). Applying rapid ‘de-facto’ HTA in resource-limited settings: Experience from Romania. Health Policy. 112(3). 202–208. 25 indexed citations

17.

Anderson, Gerard F., Kalipso Chalkidou, & Bradley Herring. (2012). High US Health-Care Spending and the Importance of Provider Payment Rates. Forum for Health Economics & Policy. 15(2). 1–22. 1 indexed citations

18.

Chalkidou, Kalipso. (2009). Comparative effectiveness review within the U.K.'s National Institute for Health and Clinical Excellence.. PubMed. 59. 1–12. 26 indexed citations

19.

Faden, Ruth, Kalipso Chalkidou, John Appleby, Hugh Waters, & Jonathon P. Leider. (2009). Expensive Cancer Drugs: A Comparison between the United States and the United Kingdom. Milbank Quarterly. 87(4). 789–819. 47 indexed citations

20.

Thorpe, Kevin E., Merrick Zwarenstein, Andrew D Oxman, et al.. (2009). A pragmatic–explanatory continuum indicator summary (PRECIS): a tool to help trial designers. Journal of Clinical Epidemiology. 62(5). 464–475. 986 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact